Lilly Accelerates RIM Deployment with Agile Approach

Eli Lilly struggled to deliver regulatory capabilities at scale using traditional waterfall methodology, so it shifted to an agile approach with quarterly releases and cross-functional Discovery Action Teams, plus weekly reviews. Within two years, the page states Lilly grew Veeva RIM users from 300 to approximately 5,000, delivered six releases, and increased monthly submissions output by 50% (from 400 to 600 submissions). Adding Veeva Submissions Publishing enabled continuous parallel authoring and publishing validation, reducing revision cycles and improving submission quality.

Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.